Equities Analysts Issue Forecasts for RIGL FY2025 Earnings
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Rigel Pharmaceuticals in a report released on Wednesday, May 7th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will earn $1.20 per share for the year, down from […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Rigel Pharmaceuticals in a report released on Wednesday, May 7th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will earn $1.20 per share for the year, down from […]
